Sources Comparative review of semaglutide and tirzepatide mechanisms (Pharmacological Research, ScienceDirect) A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity (Diabetes, American Diabetes Association) GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models (PMC) Anorectic and aversive effects of GLP-1 receptor agonism mediated by brainstem CCK neurons, modulated by GIP (PMC) Head-to-Head Trial Compares Weight Loss Drugs (Weill Cornell Medicine Newsroom, reporting NEJM SURMOUNT-5) Head-to-head comparison of tirzepatide and semaglutide for weight loss: systematic review and meta-analysis (PubMed) Are You a GLP-1 Nonresponder
Contributing Factors Beyond Weight Loss Several factors compound the hair loss risk during GLP-1 treatment: Reduced caloric intake Decreased appetite means fewer nutrients for hair follicle metabolism Protein insufficiency Hair is 95% keratin protein
CagriSema is two drugs in one syringe
Think oats, chia seeds, flaxseeds, and psyllium husk
It should deliver meaningful amounts of the nutrients women are most likely to need, in forms the body can actually use
Anonymous Rated 5 out of 5 5 stars
